Kennedy Capital Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.24M | Sell |
38,146
-3,372
| -8% | -$464K | 0.13% | 283 |
|
|
2025
Q1 | $7.49M | Buy |
41,518
+13,807
| +50% | +$2.49M | 0.18% | 198 |
|
|
2024
Q4 | $4.34M | Buy |
27,711
+22,517
| +434% | +$3.53M | 0.1% | 351 |
|
|
2024
Q3 | $945K | Buy |
5,194
+237
| +5% | +$43.1K | 0.02% | 595 |
|
|
2024
Q2 | $910K | Buy |
4,957
+2,056
| +71% | +$378K | 0.02% | 600 |
|
|
2024
Q1 | $516K | Sell |
2,901
-26,772
| -90% | -$4.76M | 0.01% | 657 |
|
|
2023
Q4 | $3.68M | Buy |
+29,673
| New | +$3.68M | 0.08% | 365 |
|
|
2023
Q2 | – | Sell |
-25,807
| Closed | -$2.07M | – | 681 |
|
|
2023
Q1 | $2.07M | Sell |
25,807
-13
| -0.1% | -$1.04K | 0.06% | 396 |
|
|
2022
Q4 | $2.05M | Sell |
25,820
-1,465
| -5% | -$116K | 0.06% | 411 |
|
|
2022
Q3 | $1.9M | Buy |
+27,285
| New | +$1.9M | 0.06% | 423 |
|